Delivery Order SPE2DR25D1017-SPE2DR26F9BDM
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,052.80 on December 11, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 5, 2026. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was executed on December 8, 2025, with an ultimate completion date of December 30, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,336.38 on September 18, 2025, for SPIKEVAX 2025-26 vaccine doses (12 years and up) in 0.5mL syringes. The contract carries a firm fixed price and is scheduled for completion by October 9, 2025. This non-set-aside award is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's role as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a $1,683.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5mL syringes. This contract, issued December 8, 2025, with completion targeted for December 30, 2025, represents a non-set-aside competitive award supporting federal medical supply procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.02 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This firm fixed price, non-set-aside delivery order was awarded on November 17, 2025, with an ultimate completion date of December 9, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes, valued at $14,201.30. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement practices. The contract is scheduled for completion by December 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,431.78 on June 18, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and older) in 0.5 mL syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,083.04 delivery order on June 2, 2025, for SPIKEVAX 2024-25 vaccine (12 years and up), 0.5ML syringes, with a completion date of June 24, 2025. This competitively awarded, firm fixed-price delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and up) in 0.5ML syringes, with a ceiling value of $1,177.48 and completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction reflecting the agency's procurement of influenza vaccines to support military healthcare operations. The order was placed under...
- The Defense Logistics Agency awarded a $16,480.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and older) in 0.5 mL syringes. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by December 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BDMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,683.33 on December 10, 2025, for the supply of SPIKEVAX 2025-26 (12 years and up) vaccine in 0.5 mL syringes. The contract represents a firm fixed-price delivery order with an ultimate completion date of January 2, 2026, and was competitively awarded without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. The company's consistent track record of competitive awards with firm fixed pricing demonstrates its capability to meet federal medical supply requirements across multiple therapeutic domains and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/9/25 |